Lataa...
SOX9 drives WNT pathway activation in prostate cancer
The transcription factor SOX9 is critical for prostate development, and dysregulation of SOX9 is implicated in prostate cancer (PCa). However, the SOX9-dependent genes and pathways involved in both normal and neoplastic prostate epithelium are largely unknown. Here, we performed SOX9 ChIP sequencing...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855922/ https://ncbi.nlm.nih.gov/pubmed/27043282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI78815 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|